Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Cash from Investing Activities of -$475.3 million in Q1 2026, up 44.59% quarter-over-quarter from -$857.9 million in Q4 2025, and down 187.82% on a YoY basis from $541.2 million in Q1 2025.
Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$475.3 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 187.82% year-over-year to -$475.3 million; the TTM figure through Mar 2026 stood at -$2.2 billion (down 33.6% YoY), while the FY2025 annual figure was -$857.9 million, down 40.11% from the prior year.
- Cash from Investing Activities was -$475.3 million for Q1 2026 at Koninklijke Philips, up from -$857.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$165.1 million in Q1 2025 to a low of -$1.5 billion in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$584.7 million across 5 years, with a median of -$520.6 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 75.77% in 2022, then slumped 187.82% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$1.5 billion in 2022, then soared by 54.89% to -$684.3 million in 2023, then grew by 10.52% to -$612.3 million in 2024, then plunged by 40.11% to -$857.9 million in 2025, then surged by 44.59% to -$475.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$475.3 million (Q1 2026), -$857.9 million (Q4 2025), and -$632.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -159.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -475.32 Mn |
| Mar 31, 2026 | -475.32 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Jun 30, 2024 | -363.99 Mn |
| Jun 30, 2024 | -363.99 Mn |
| Mar 31, 2024 | -190.11 Mn |
| Mar 31, 2024 | -190.11 Mn |
| Dec 31, 2023 | -684.30 Mn |
| Dec 31, 2023 | -684.30 Mn |